Morrison, Jay
,
Hasselblad, Michele
Kleinpell, Ruth
Buie, Reagan
Ariosto, Deborah
Hardiman, Erin
Osborn, Stephen W.
Lindsell, Christopher J.
Funding for this research was provided by:
Vanderbilt Institute for Clinical and Translational Research (UL1 TR002243)
Article History
Received: 1 October 2019
Accepted: 24 March 2020
First Online: 24 May 2020
Ethics approval and consent to participate
: The trial was determined by the Institutional Review Board (IRB) to pose minimal risk to patient participants because the proactive screening is being conducted as part of clinical care and is intended to enhance patient care. Furthermore, all patient data collected for the purposes of the study are generated as part of routine clinical care and are obtained by data extraction from the electronic health record. A waiver of informed consent for patients was requested because it was expected that substantial bias would be introduced by requiring consent, and this would make it impracticable to conduct this research in a meaningful way; the IRB approved the waiver of informed consent. Informed consent was required for clinical staff completing online surveys assessing their comfort with and confidence in their ability to manage patients exhibiting disruptive, threatening, or acting out behavior.
: Not applicable.
: The authors declare that they have no competing interests.